loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Prestwick3_000879

    Client Email Product
    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Menu

    Prestwick3_000879

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,516Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enforcement Report - Week of September 13, 2023
    Enforcement Report - Week of September 13, 2023

    13 Sep 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-13-2023-60327.pdf

    FDA
    13 Sep 2023
    Share Share
    Enforcement Report - Week of March 15, 2023
    Enforcement Report - Week of March 15, 2023

    15 Mar 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-15-2023-86840.pdf

    FDA
    15 Mar 2023
    Share Share
    Initiator Pharma obtains approval to begin trial for pain-reducing effects
    Initiator Pharma obtains approval to begin trial for pain-reducing effects

    27 Nov 2021

    // CLINICALTRIALSARENA

    https://www.clinicaltrialsarena.com/news/initiator-approval-trial-pain-reducing-effects/

    CLINICALTRIALSARENA
    27 Nov 2021
    Share Share
    Averitas Pharma Announces FDA Acceptance of sNDA Filing for QUTENZA
    Averitas Pharma Announces FDA Acceptance of sNDA Filing for QUTENZA

    19 Dec 2019

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/averitas-pharma-announces-fda-acceptance-of-snda-filing-for-qutenza-capsaicin-8-patch-for-the-treatment-of-neuropathic-pain-associated-with-diabetic-peripheral-neuropathy-300976908.html

    PR NEWSWIRE
    19 Dec 2019
    Share Share
    Averitas Pharma Announces FDA Acceptance of sNDA Filing for QUTENZA® (capsaicin)
    Averitas Pharma Announces FDA Acceptance of sNDA Filing for QUTENZA® (capsaicin)

    18 Dec 2019

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/averitas-pharma-announces-fda-acceptance-of-snda-filing-for-qutenza-capsaicin-8-patch-for-the-treatment-of-neuropathic-pain-associated-with-diabetic-peripheral-neuropathy-300976908.html

    PR NEWSWIRE
    18 Dec 2019
    Share Share
    Centrexion Therapeutics Announces Issuance of U.S. Composition of Matter Patent
    Centrexion Therapeutics Announces Issuance of U.S. Composition of Matter Patent

    03 Dec 2019

    // GLOBE NEWSWIRE

    https://www.globenewswire.com/news-release/2019/12/03/1955486/0/en/Centrexion-Therapeutics-Announces-Issuance-of-U-S-Composition-of-Matter-Patent-for-Lead-Pipeline-Candidate-CNTX-4975.html

    GLOBE NEWSWIRE
    03 Dec 2019
    Share Share